Björnsson E, Jørgensen K, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3938178 A1, 2025-03-03.
Lee S K, Yamamoto T, Anderson J P. "Method for the Synthesis of Potassium (5-chloropyrimidin-2-yl)trifluoroborate" [P]. US Patent, US 10382101 B2, 2015-08-06.
Yamamoto T, Klinger H, Anderson J P. "A Process for Preparing High-Purity Potassium (5-chloropyrimidin-2-yl)trifluoroborate" [P]. US Patent, US 9708115 B2, 2024-02-28.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2016, 878, (1), 7933-7944.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2012, 1828, (3), 1514-1537.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Potassium (5-chloropyrimidin-2-yl)trifluoroborate Using HRMS and NMR". Anal. Chem., 2020, 691, (1), 6069-6079.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2024, 983, (4), 8987-9001.